Drug Shortage Report for CYSTO-CONRAY II

Last updated on 2025-05-01 History
Report ID 198134
Drug Identification Number 00397466
Brand name CYSTO-CONRAY II
Common or Proper name Iothalamate Meglumine Injection 17.2% w/v
Company Name LIEBEL-FLARSHEIM COMPANY LLC
Market Status MARKETED
Active Ingredient(s) IOTHALAMATE MEGLUMINE
Strength(s) 172MG
Dosage form(s) SOLUTION
Route of administration URETHRAL URETHRAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 250 mL
ATC code V08AA
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-08-05
Actual start date
Estimated end date
Actual end date 2025-04-30
Shortage status Resolved
Updated date 2025-05-01
Company comments Marketing status is changed to Dormant. Product has not been marketed in last 12 months.
Health Canada comments
Tier 3 Status No
Contact Address 8800 DURANT RD.
RALEIGH, NORTH CAROLINA
UNITED STATES 27616
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-05-01 English Compare
v9 2025-04-30 French Compare
v8 2025-04-30 English Compare
v7 2025-04-30 English Compare
v6 2025-04-30 English Compare
v5 2025-04-30 French Compare
v4 2025-04-30 English Compare
v3 2023-08-06 English Compare
v2 2023-07-11 French Compare
v1 2023-07-11 English Compare

Showing 1 to 10 of 10